Antibiotic resistance: location, location, location.
暂无分享,去创建一个
[1] G. Duckworth,et al. Surveillance and epidemiology of MRSA bacteraemia in the UK. , 2005, The Journal of antimicrobial chemotherapy.
[2] J. Jordens. Characterisation of non-capsulate Haemophilus influenzae by repetitive extragenic palindromic (REP)-PCR. , 1998, Journal of medical microbiology.
[3] O. Stine,et al. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. , 2006, The American journal of medicine.
[4] Jon Brazier,et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.
[5] R. Masterton,et al. Trends in antimicrobial susceptibility in UK centres: the MYSTIC Programme (1997-2002). , 2006, International journal of antimicrobial agents.
[6] P. Hsueh,et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). , 2006, International journal of antimicrobial agents.
[7] P. Donnan,et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data , 2004, BMJ : British Medical Journal.
[9] M. Gardam,et al. Complete Nucleotide Sequence of a 92-Kilobase Plasmid Harboring the CTX-M-15 Extended-Spectrum Beta-Lactamase Involved in an Outbreak in Long-Term-Care Facilities in Toronto, Canada , 2004, Antimicrobial Agents and Chemotherapy.
[10] Ronald N. Jones,et al. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. , 2004, Diagnostic microbiology and infectious disease.
[11] F. Haaijer-Ruskamp,et al. Cross-cultural differences in lay attitudes and utilisation of antibiotics in a Belgian and a Dutch city. , 2002, Patient education and counseling.
[12] S. Salmaso,et al. Pneumococcal vaccination policy in Europe. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[13] M. Kaufmann,et al. Harmonization of Pulsed-Field Gel Electrophoresis Protocols for Epidemiological Typing of Strains of Methicillin-Resistant Staphylococcus aureus: a Single Approach Developed by Consensus in 10 European Laboratories and Its Application for Tracing the Spread of Related Strains , 2003, Journal of Clinical Microbiology.
[14] N. Woodford,et al. Multiresistant acinetobacter in the UK: how big a threat? , 2004, The Journal of hospital infection.
[15] M. Kaufmann,et al. Occurrence of Carbapenem-Resistant Acinetobacter baumannii Clones at Multiple Hospitals in London and Southeast England , 2006, Journal of Clinical Microbiology.
[16] M. Wilcox,et al. Does hospital cleanliness correlate with methicillin-resistant Staphylococcus aureus bacteraemia rates? , 2006, The Journal of hospital infection.
[17] R. Raz,et al. Risk Factors for the Development of Extended-Spectrum Beta-Lactamase-Producing Bacteria in Nonhospitalized Patients , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[18] A. Voss,et al. Methicillin-ResistantStaphylococcus aureus in Europe , 2005, European Journal of Clinical Microbiology and Infectious Diseases.
[19] A. Widmer,et al. Transatlantic spread of the USA300 clone of MRSA. , 2005, The New England journal of medicine.
[20] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[21] Jyoti Gupta,et al. A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York City , 2006, Annals of Clinical Microbiology and Antimicrobials.
[22] V L Yu,et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. , 1991, Annals of internal medicine.
[23] J. Bartlett. Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.
[24] J. Heritage,et al. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward. , 1995, The Journal of antimicrobial chemotherapy.
[25] S. Stone. Soil, seed and climate: developing a strategy for prevention and management of infections in UK nursing homes. , 1999, The Journal of hospital infection.
[26] J. Richardson,et al. Characterization of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. , 1993, The Journal of hospital infection.
[27] S. Cosgrove,et al. Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacterspp , 2001, Antimicrobial Agents and Chemotherapy.
[28] J. Hamilton-miller,et al. Methicillin-resistant Staphylococcus aureus. , 1989, The New England journal of medicine.
[29] R. Polk. Antimicrobial formularies: can they minimize antimicrobial resistance? , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[30] H. Žemličková,et al. Emergence of EMRSA-15 clone in hospitals throughout the Czech Republic. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[31] O. Cars,et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. , 2002, Emerging infectious diseases.
[32] N. Woodford,et al. CTX-M: changing the face of ESBLs in Europe. , 2006, The Journal of antimicrobial chemotherapy.
[33] J. Quinn,et al. Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40 , 2006, Antimicrobial Agents and Chemotherapy.
[34] M. Kaufmann,et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. , 2004, The Journal of antimicrobial chemotherapy.
[35] A. Oliver,et al. Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period , 2002, Journal of Clinical Microbiology.
[36] C. Mcnulty,et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. , 2006, The Journal of antimicrobial chemotherapy.
[37] E. Bryce,et al. Focused Microbiological Surveillance and Gram-Negative Beta-Lactamase-Mediated Resistance in an Intensive Care Unit , 1995, Infection Control & Hospital Epidemiology.
[38] Outi Lyytikäinen,et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002 , 2004, Emerging infectious diseases.
[39] John M Boyce,et al. Do Infection Control Measures Work for Methicillin-Resistant Staphylococcus aureus? , 2004, Infection Control & Hospital Epidemiology.
[40] M. Farrington,et al. Effects on nursing workload of different methicillin-resistant Staphylococcus aureus (MRSA) control strategies. , 2000, The Journal of hospital infection.
[41] C. Mcnulty,et al. How should general practitioners investigate suspected urinary tract infection? Variations in laboratory-confirmed bacteriuria in South West England. , 2004, Communicable disease and public health.
[42] G. Saunders. Methicillin resistant Staphylococcus aureus. , 2006, The West Indian medical journal.
[43] H. Goossens,et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.
[44] A. Fraise,et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. , 2006, The Journal of antimicrobial chemotherapy.
[45] J. Rodríguez-Baño,et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] I. Montesinos,et al. Changes in the epidemiology of meticillin-resistant Staphylococcus aureus associated with the emergence of EMRSA-16 at a university hospital. , 2006, The Journal of hospital infection.
[47] R. Marples,et al. A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16) , 1995, The Journal of hospital infection.
[48] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[49] D. Livermore,et al. Surveillance of antimicrobial resistance , 1998, BMJ.
[50] D. Livermore,et al. Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test. , 2001, The Journal of antimicrobial chemotherapy.
[51] F. Baquero,et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). , 2006, The Journal of antimicrobial chemotherapy.
[52] M. Mulvey,et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[53] D. Diekema,et al. Importance of Control Group Selection for Evaluating Antimicrobial Use as a Risk Factor for Methicillin-Resistant Staphylococcus Aureus Bacteremia , 2005, Infection Control & Hospital Epidemiology.
[54] N. Woodford,et al. Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom. , 2006, The Journal of antimicrobial chemotherapy.
[55] A. Charlett,et al. In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles. , 2003, International Journal of Antimicrobial Agents.
[56] D. Felmingham. The need for antimicrobial resistance surveillance. , 2002, The Journal of antimicrobial chemotherapy.
[57] B. Cookson,et al. Staphylococcus aureus Isolates Carrying Panton-Valentine Leucocidin Genes in England and Wales: Frequency, Characterization, and Association with Clinical Disease , 2005, Journal of Clinical Microbiology.
[58] A. MacGowan,et al. Surveillance of antimicrobial resistance , 1998, The Lancet.
[59] J. Rodríguez-Baño,et al. Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients , 2004, Journal of Clinical Microbiology.
[60] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[61] J. Patel,et al. Characterization of a Strain of Community-AssociatedMethicillin-Resistant Staphylococcus aureus WidelyDisseminated in the UnitedStates , 2006, Journal of Clinical Microbiology.
[62] T. Sandberg,et al. [How an outbreak of MRSA in Gothenburg was eliminated: by strict hygienic routines and massive control-culture program]. , 2002, Läkartidningen.
[63] I. Gould,et al. Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes? , 2005, The Journal of hospital infection.
[64] H. Wertheim,et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. , 2004, The Journal of hospital infection.